Mindfulness-based Short Intervention for Seniors - Decentering Effects on Cognitive Functions and Psychological Distress

November 13, 2019 updated by: Ophir Leshets, Ben-Gurion University of the Negev
The present study examined the effect of a short Mindfulness-based intervention emphasizing a 'decentering' component on elderly seniors. Methods: 30 community seniors (Mage= 74.7) performed either 'decentering' intervention, guided imagery intervention, or control care as usual. The 8-week interventions included weekly 20-minute sessions and daily 10-minute home practice. Participants underwent a cognitive and emotional assessment before and after the interventions, which included filling out questionnaires and performing the Simon task. Trial registration: The study follows the principles of the Declaration of Helsinki, approved by the committee in Beer-Yaacov Hospital, Israel (number 579) on 24 Oct. 2017.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Emek-Hefer, Israel, 4025000
        • Ruppin academic center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age 65 and above
  • membership in the study's specific enrollment community centers
  • scoring 24 and above in the Mini-Mental State Examination (MMSE).

Exclusion Criteria:

  • age under 65
  • not being a member in the study's specific enrollment community centers
  • scoring under 24 in the Mini-Mental State Examination (MMSE).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: decentering group
MBSR focused on a "decentering" component (i.e. individuals observe their feelings and thoughts as ephemeral events, with no reactivity, alongside with acceptance).
examined a mindfulness-based intervention focused on a decentering component, that is suitable for elders, aimed to influence on cognitive measures and psychological distress.
Experimental: guided imagery group
a group practicing in guided imagery sessions.
relaxing guided imagery including breathing exercises.
No Intervention: control group
usual care group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Simon task- change from baseline to after intervention
Time Frame: at baseline and through intervention's completion, 10 weeks.
a cognitive task, assessing control processes under speeded conditions, measured by response time and accuracy rate. shorter response time and higher accuracy rate indicate better performance.
at baseline and through intervention's completion, 10 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FFMQ- change from baseline to after intervention
Time Frame: at baseline and through intervention's completion, 10 weeks.
The Five-Fact Mindfulness Questionnaire, a manipulation check of mindfulness, ranging from 1 to 5, with higher score indicating higher mindfulness level
at baseline and through intervention's completion, 10 weeks.
PWB questionnaire- change from baseline to after intervention
Time Frame: at baseline and through intervention's completion, 10 weeks.
The Psychological Well-Being Questionnaire, ranging from 1 to 6, with higher score indicating higher well-being level
at baseline and through intervention's completion, 10 weeks.
MMSE- change from baseline to after intervention
Time Frame: at baseline and through intervention's completion, 10 weeks.
the Mini-Mental State examination: a cognitive function measure for elders, used to determine participation eligibility. the animation score ranges between 0 to 30, with higher score indicating better cognitive functioning
at baseline and through intervention's completion, 10 weeks.
PHQ-9- change from baseline to after intervention
Time Frame: at baseline and through intervention's completion, 10 weeks.
The Patient Health Questionnaire - a depression levels measure, ranging from 0 to 3, with higher score indicating higher depression level
at baseline and through intervention's completion, 10 weeks.
BDI-II- change from baseline to after intervention
Time Frame: at baseline and through intervention's completion, 10 weeks.
The Beck Depression Inventory-II- a depression levels measure, ranging from 1 to 4, with higher score indicating higher depression level
at baseline and through intervention's completion, 10 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2017

Primary Completion (Actual)

August 1, 2018

Study Completion (Actual)

August 1, 2018

Study Registration Dates

First Submitted

November 1, 2019

First Submitted That Met QC Criteria

November 13, 2019

First Posted (Actual)

November 15, 2019

Study Record Updates

Last Update Posted (Actual)

November 15, 2019

Last Update Submitted That Met QC Criteria

November 13, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 597

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Change

Clinical Trials on decentering

3
Subscribe